ArticleDeutsche medizinische Wochenschrift (1946)2026
[Characterization of imported dengue fever cases in Germany - Results of a pilot project].
Article in Deutsche medizinische Wochenschrift (1946), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Background: Dengue fever is a mosquito-borne viral infectious disease with an estimated 100-400 million infections worldwide every year. The currently highest case numbers are also reflected in the specialized centers in Germany. A pilot project for the surveillance of highly infectious imported diseases at the tropical medicine centers in Berlin, Heidelberg and Augsburg used dengue fever to pilot joint data collection, transmission and analysis. Methods: Patients with dengue fever were included in the survey. Demographic, anamnestic and clinical-laboratory data were recorded and then transferred to an online database (RedCap) accessible to all participating centers. Results: In the pilot phase (August to December 2023) 42 patients were included (median age: 35.5 years; travel duration: median 20 days). The countries of infection were South (East) Asia (64.3%), Central America (30.9%) and Africa (4.8%). The mostly classic symptoms (fever, headache, joint and muscle pain, exanthema) began during the trip in almost two thirds of cases. The diagnosis was based on the detection of the NS1 antigen in 71.4% and on serology in 28.6%. The piloted system proved to be practicable for detecting infectious threats in terms of pandemic preparedness. Conclusion: The joint detection of an infectious disease was successfully piloted. Dengue fever presented itself in its classic form. Growing case numbers and the risk of autochthonous transmission are increasingly bringing dengue fever into the focus of differential diagnosis in Germany.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.